BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION AND THE LOCALIZATION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS

被引：0
|
作者：
Manzella, L. [1 ]
Massimino, M. [1 ]
Fallica, M. [1 ]
Consoli, M. L. [1 ]
Aloisi, A. [1 ]
Messina, A. [1 ]
Vigneri, P. [1 ]
机构：
[1] Univ Catania, Dept Biomed Sci, Sect Gen Pathol, Catania, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C052
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [41] Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr-Abl mutations and mutational analysis
    Soverini, Simona
    Martinelli, Giovanni
    Rosti, Gianantonio
    Iacobucci, Ilaria
    Baccarani, Michele
    PHARMACOGENOMICS, 2012, 13 (11) : 1271 - 1284
  • [42] Inhibitory effects of 5-S-GAD on phosphorylation of V-SRC and BCR-ABL tyrosine kinase
    Leem, JY
    Park, HY
    Fukazawa, H
    Uehara, Y
    Natori, S
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1998, 21 (07) : 784 - 785
  • [43] BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
    Oliver Hantschel
    Wolfgang Warsch
    Eva Eckelhart
    Ines Kaupe
    Florian Grebien
    Kay-Uwe Wagner
    Giulio Superti-Furga
    Veronika Sexl
    Nature Chemical Biology, 2012, 8 (3) : 285 - 293
  • [44] BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
    Hantschel, Oliver
    Warsch, Wolfgang
    Eckelhart, Eva
    Kaupe, Ines
    Grebien, Florian
    Wagner, Kay-Uwe
    Superti-Furga, Giulio
    Sexl, Veronika
    NATURE CHEMICAL BIOLOGY, 2012, 8 (03) : 285 - 293
  • [45] BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naive and -exposed Southeast Asian chronic myeloid leukemia patients
    Wongboonma, Wanwisa
    Thongnoppakhun, Wanna
    Auewarakul, Chirayu U.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 92 (02) : 259 - 265
  • [46] Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
    Corbin, Amie S.
    Agarwal, Anupriya
    Loriaux, Marc
    Cortes, Jorge
    Deininger, Michael W.
    Druker, Brian J.
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (01): : 396 - 409
  • [47] Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells
    Preisinger, C.
    Schwarz, J. P.
    Bleijerveld, O. B.
    Corradini, E.
    Mueller, P. J.
    Anderson, K. I.
    Kolch, W.
    Scholten, A.
    Heck, A. J. R.
    LEUKEMIA, 2013, 27 (03) : 743 - 746
  • [48] Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells
    C Preisinger
    J P Schwarz
    O B Bleijerveld
    E Corradini
    P J Müller
    K I Anderson
    W Kolch
    A Scholten
    A J R Heck
    Leukemia, 2013, 27 : 743 - 746
  • [49] THE RATE OF BCR-ABL DECLINE AS AN OPTIMIZED PREDICTOR OF OUTCOME FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE ON TREATMENT WITH TYROSINE KINASE INHIBITORS
    Fominykh, M.
    Shuvaev, V.
    Martynkevich, I.
    Tsaur, G.
    Bederak, N.
    Chelysheva, E.
    Shukhov, O.
    Abdullaev, A.
    Udaleva, V.
    Golovchenko, R.
    Zotova, I.
    Shikhbabaeva, D.
    Polushkina, L.
    Petrova, E.
    Ivanova, M.
    Martynenko, L.
    Kleina, E.
    Cybakova, N.
    Turkina, A.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2015, 100 : 444 - 444
  • [50] ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
    Ernst, Thomas
    Hoffmann, Jana
    Erben, Philipp
    Hanfstein, Benjamin
    Leitner, Armin
    Hehlmann, Ruediger
    Hochhaus, Andreas
    Mueller, Martin C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (09): : 1389 - 1393
12345